Study reveals significant global disparities in cancer care across different countries
Researchers address increasing rates of cancer incidence and mortality in developing countries, and challenges in accessing treatments.
Wiley
A recent analysis reveals striking disparities in the cost and availability of cancer drugs across different regions of the globe, with significant gaps between high- and low-income countries. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
The analysis, which drew on relevant published studies and reviews related to cancer and the availability of cancer treatments, predicts that there will be an estimated 28.4 million new cancer cases worldwide in 2040 alone. In the coming years, cancer incidence is expected to increase most significantly in low-income countries. Cancer mortality rates are also increasing in low-income countries, whereas they have leveled off in developed countries.
Research indicates that inequity in access to therapy, lack of proper screening, persistent carcinogenic risk factors, and inadequate healthcare infrastructure are major contributors to the higher cancer incidence and cancer-related mortality rates observed in low-income countries compared with high-income countries. Also, clinicians’ current understanding of cancer and its optimal treatment is primarily based on research conducted in high-income countries, whose residents may differ from individuals in middle- and low-income countries.
Studies reveal that economics can be a major challenge for optimal cancer care around the world. Newer cancer drugs such as immunotherapy medications can cost thousands of dollars more per year than standard chemotherapy. Also, low-income countries spend less of their total gross domestic product on cancer care than high-income countries, yet they often must pay more for the same essential cancer drugs.
“Cancer incidence and mortality are on the rise globally and are expected to disproportionately affect people in low- and middle-income countries. Unfortunately, access to newer cancer therapeutics is far more restricted in low- and middle-income countries due to prohibitive costs,” said senior author Fadlo R. Khuri, MD, of the American University of Beirut Medical Center, in Lebanon. “In this paper, we analyze the data and propose a few solutions that could help alleviate these worsening disparities—including the use of quality generics and biosimilars and the implementation of universal healthcare coverage and international medical funding.”
Additional information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the CANCER Newsroom upon online publication. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com
Full Citation:
“Global Disparities in Cancer Care: Bridging the Gap in Affordability and Access to Medications between High and Low-Income Countries.” Arafat H. Tfayli, Laura N. El-Halabi, and Fadlo R. Khuri. CANCER; Published Online: November 18, 2024 (DOI: 10.1002/cncr.35590).
URL Upon Publication: http://doi.wiley.com/10.1002/cncr.35590
Author Contact: Simon Kachar, Executive Director of Communications at the American University of Beirut, at sk158@aub.edu.lb
About the Journal
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online. Follow CANCER on X @JournalCancer and Instagram @ACSJournalCancer, and stay up to date with the American Cancer Society Journals on LinkedIn.
About Wiley
Wiley is one of the world’s largest publishers and a trusted leader in research and learning. Our industry-leading content, services, platforms, and knowledge networks are tailored to meet the evolving needs of our customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. We empower knowledge-seekers to transform today’s biggest obstacles into tomorrow’s brightest opportunities. For more than two centuries, Wiley has been delivering on its timeless mission to unlock human potential. Visit us at Wiley.com. Follow us on Facebook, X, LinkedIn and Instagram.
Journal
Cancer
Article Title
Global Disparities in Cancer Care: Bridging the Gap in Affordability and Access to Medications between High and Low-Income Countries
Article Publication Date
18-Nov-2024
No comments:
Post a Comment